Felicia Williams - Jan 26, 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role
Director
Signature
/s/ F. Mark Reuter as Attorney-in-Fact for Felicia Williams
Stock symbol
VIVO
Transactions as of
Jan 26, 2022
Transactions value $
$0
Form type
4
Date filed
1/28/2022, 10:47 AM
Previous filing
May 7, 2021
Next filing
May 6, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Award $0 +3.01K +41.48% $0.00 10.3K Jan 26, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Award $0 +5.66K $0.00 5.66K Jan 26, 2022 Common Stock 5.66K $20.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.
F2 These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.